SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-008624
Filing Date
2018-11-06
Accepted
2018-11-06 16:06:32
Documents
56
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rigl-20180930x10q.htm 10-Q 1870354
2 EX-31.1 rigl-20180930ex3113d77a3.htm EX-31.1 17792
3 EX-31.2 rigl-20180930ex312177e54.htm EX-31.2 17780
4 EX-32.1 rigl-20180930ex32146b1ef.htm EX-32.1 9435
  Complete submission text file 0001558370-18-008624.txt   5357091

Data Files

Seq Description Document Type Size
5 EX-101.INS rigl-20180930.xml EX-101.INS 1067774
6 EX-101.SCH rigl-20180930.xsd EX-101.SCH 31501
7 EX-101.CAL rigl-20180930_cal.xml EX-101.CAL 39402
8 EX-101.DEF rigl-20180930_def.xml EX-101.DEF 101126
9 EX-101.LAB rigl-20180930_lab.xml EX-101.LAB 287658
10 EX-101.PRE rigl-20180930_pre.xml EX-101.PRE 207639
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29889 | Film No.: 181162995
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1